Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
BEGEMANN BRETT D reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Brett D. Begemann increased his deferred compensation balance through phantom stock units rather than cash fees. On April 8, 2026, he was credited with 1,159 Phantom Stock Units valued at $74.27 each and an additional 408 units at $0 under the company’s Directors' Deferred Compensation Plan. These units track the value of one share of Eastman common stock but are payable only in cash after his board service ends. Following these awards and fee deferrals, Begemann holds 58,408 phantom stock units directly, including amounts from voluntary and automatic fee deferrals and reinvested dividend equivalents.
Haynesworth Linnie M reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Linnie M. Haynesworth received 408 Phantom Stock Units on April 8, 2026, as a grant under the company’s Directors’ Deferred Compensation Plan. These units track the value of one share of Eastman common stock but are payable only in cash after board service ends.
The award increased Haynesworth’s Phantom Stock Unit balance to 5,640 units. The grant reflects an automatic deferral of a portion of the director’s annual retainer fees, with dividend equivalents reinvested into additional units, and does not represent an open-market stock purchase or sale.
OBRIEN JAMES J /KY reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director James J. O'Brien received 408 Phantom Stock Units credited under the company’s Directors' Deferred Compensation Plan. These units mirror the market value of one share of common stock each but are payable only in cash after he ceases serving as a director.
The award represents an automatic deferral of a portion of his annual retainer fees that would otherwise have been paid in cash. Following this grant, O'Brien holds a total of 18,137 Phantom Stock Units, which also include dividend equivalents that have been reinvested into additional units.
Alfonso Humberto P reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Humberto P. Alfonso reported two compensation-related grants of Phantom Stock Units tied to company common stock. On April 8, 2026, he was credited with 988 Phantom Stock Units at a reference value of $74.27 per unit and 408 additional units at $0.00 per unit.
After these transactions, his reported Phantom Stock Unit balance increased to 55,961 units. The footnotes explain these units are credited under the Directors' Deferred Compensation Plan, have a value equal to one share of Eastman Chemical common stock, and are payable only in cash after his service as a director ends.
The filing notes these units arise from a mix of voluntary deferral of retainer fees, automatic deferral of annual retainer fees into a director stock account, and dividend equivalents reinvested into additional Phantom Stock Units. These are administrative, non-market transactions rather than open-market share purchases or sales.
Holder Julie Fasone reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Julie Fasone Holder received 408 Phantom Stock Units as a compensation award. These units are credited under the Directors' Deferred Compensation Plan, with each unit valued like one share of Eastman common stock but payable only in cash after she leaves the board.
This grant arose from the automatic deferral of a portion of her annual director retainer that would otherwise have been paid in cash, and it also reflects dividend equivalents that are reinvested into additional Phantom Stock Units. Following this award, she now holds a total of 15,051 Phantom Stock Units.
SLAGER DONALD W reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Donald W. Slager received a compensation grant of 408 Phantom Stock Units. These units were credited under the Directors' Deferred Compensation Plan at no purchase price and each unit tracks the value of one share of common stock.
The award represents an automatic deferral of a portion of the director’s annual cash retainer, with amounts payable only in cash after his service as a director ends. Following this grant, Slager holds a total of 1,699 Phantom Stock Units, including units from prior awards and dividend equivalents reinvested in additional units.
HORNBAKER RENEE J reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Renee J. Hornbaker received an award of 408 Phantom Stock Units tied to the value of the company’s common stock. These units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of her annual retainer fees.
Each Phantom Stock Unit is payable only in cash after she terminates service as a director and includes dividend equivalents reinvested into additional units. After this grant, she holds a total of 51,107 Phantom Stock Units.
Mink Kim Ann reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Kim Ann Mink received a grant of 408 Phantom Stock Units on April 8, 2026. These units track the value of one share of common stock each but are payable only in cash after her service as a director ends. The grant represents an automatic deferral of a portion of her annual cash retainer fees and includes dividend equivalents reinvested in additional units. Following this award, she holds a total of 15,653 Phantom Stock Units credited under the Directors' Deferred Compensation Plan.
Eastman Chemical Co — Schedule 13G/A (Amendment No. 17)
The Vanguard Group reports no beneficial ownership of Eastman Chemical Co. common stock, listing 0 shares and 0% of the class. The filing explains that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538.